10.1
Biopharmaceutical Factors Influencing Drug Product Design: Overview
View the full transcript and gain access to JoVE Core videos
Q1: What factors must be considered when designing a rational drug product?
Rational drug product design requires understanding the drug's physicochemical properties, finished dosage form, nature of excipients, manufacturing methods, and administration route. Each factor influences how the drug is released, absorbed, and eliminated in the body, ultimately affecting therapeutic efficacy and patient safety.
Q2: How do excipients influence drug release and bioavailability?
Excipients, though pharmacologically inactive, significantly influence drug dissolution rate, stability, and bioavailability. In solid oral dosage forms, excipients form the matrix that controls drug release profiles. Their selection directly affects how quickly or slowly the active drug becomes available for absorption.
Q3: What role does the route of administration play in drug bioavailability?
The route of administration critically determines absorption efficiency and onset of action. Oral, intravenous, subcutaneous, and inhalation routes differ significantly in how drugs enter systemic circulation. By selecting an appropriate route and designing the formulation accordingly, bioavailability can be modulated for rapid, delayed, or prolonged absorption.
Q4: How are different dosage forms selected for specific therapeutic objectives?
Dosage forms—liquids, tablets, capsules, injectables, transdermal patches, and topical creams—are chosen based on therapeutic goals. Liquids may offer rapid onset, while extended-release tablets provide sustained therapeutic levels. Drug-device combinations like nebulizers deliver drugs directly to target sites, requiring evaluation of aerosol properties and in vivo performance.
Q5: Why is patient-specific dosing important in drug product design?
Therapeutic doses are typically adjusted based on patient weight or surface area, especially for drugs with narrow therapeutic windows. In pediatric and oncology settings, individualized dosing becomes critical to ensure safety and efficacy. This patient-centered approach accounts for physiological variations that affect drug absorption, distribution, and elimination.
Q6: How do physicochemical properties affect drug formulation compatibility?
A drug's physicochemical properties—such as solubility, stability, and particle size—directly affect its compatibility with excipients and the choice of appropriate dosage form. These properties determine which formulation strategies are viable and influence the drug's performance throughout its shelf life and in the body.
Q7: What multidisciplinary approach is needed for effective drug product design?
Rational drug product design requires integrating pharmaceutical sciences, engineering, and clinical knowledge to create products that consistently meet their intended function. This comprehensive multidisciplinary approach ensures therapeutic efficacy, patient safety, and product quality across diverse patient populations and manufacturing conditions.